Q1 2020 Akebia Therapeutics Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to Akebia Therapeutics INNO2VATE Top Line Data Readout Call and its First Quarter Financial Results and Business Highlights Conference Call. As a reminder, this call is being recorded.
I would now like to introduce your host for today's conference, Kristen Sheppard.
Thank you and good morning. My name is Kristen Sheppard, Senior Vice President of Investor Relations at Akebia. Thank you so much for joining us to discuss Akebia's top line data from INNO2VATE, our global Phase III program of our product candidate vadadustat for the treatment of anemia due to chronic kidney disease and adults dialysis dependent patients.
On today's call, we will also discuss Akebia's first quarter 2020 financial results and other recent business highlights. We issued 2 press releases this morning, one containing INNO2VATE's top line data, followed by one containing our financial results and other recent business highlights. Both of these exciting press
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |